$CALC
CalciMedica, Inc.

2021 Q3 Form 10-Q Financial Statement

#000156459021056418 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.996M $2.060M $3.119M
YoY Change 93.98%
% of Gross Profit
Research & Development $4.021M $4.757M $10.72M
YoY Change -15.47% -43.39%
% of Gross Profit
Depreciation & Amortization $136.0K $90.00K $190.0K
YoY Change 51.11% 35.71%
% of Gross Profit
Operating Expenses $8.017M $6.821M $13.84M
YoY Change 17.53% -34.19%
Operating Profit -$8.017M -$6.821M
YoY Change 17.53% -34.19%
Interest Expense $28.00K $0.00 $117.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $2.100M $56.00K
YoY Change -100.0%
Pretax Income -$7.989M -$4.720M -$13.66M
YoY Change 69.26%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.989M -$4.716M -$5.869M
YoY Change 69.4% -53.79% -42.81%
Net Earnings / Revenue
Basic Earnings Per Share -$0.38
Diluted Earnings Per Share -$375.3K -$225.0K -$713.3K
COMMON SHARES
Basic Shares Outstanding 21.29M
Diluted Shares Outstanding 21.29M

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $72.55M $95.00M $17.50M
YoY Change -23.63%
Cash & Equivalents $11.45M $94.97M $17.50M
Short-Term Investments $61.10M $0.00 $0.00
Other Short-Term Assets $1.942M $100.0K $100.0K
YoY Change 1842.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $74.50M $95.11M $17.70M
YoY Change -21.67%
LONG-TERM ASSETS
Property, Plant & Equipment $2.113M $1.788M $1.800M
YoY Change 18.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $29.00K $1.500M $3.000M
YoY Change -98.07%
Total Long-Term Assets $2.142M $3.279M $4.700M
YoY Change -34.68%
TOTAL ASSETS
Total Short-Term Assets $74.50M $95.11M $17.70M
Total Long-Term Assets $2.142M $3.279M $4.700M
Total Assets $76.64M $98.39M $22.40M
YoY Change -22.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.066M $4.562M $2.200M
YoY Change -54.71%
Accrued Expenses $1.729M $1.023M $2.300M
YoY Change 69.01%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.490M $7.741M $7.200M
YoY Change -42.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $12.00K $0.00
YoY Change
Total Long-Term Liabilities $12.00K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.490M $7.741M $7.200M
Total Long-Term Liabilities $12.00K $0.00 $0.00
Total Liabilities $4.502M $7.751M $7.200M
YoY Change -41.92%
SHAREHOLDERS EQUITY
Retained Earnings -$160.5M -$124.2M
YoY Change 29.21%
Common Stock $2.000K $214.8M
YoY Change -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $72.14M $90.63M -$116.2M
YoY Change
Total Liabilities & Shareholders Equity $76.64M $98.39M $22.40M
YoY Change -22.1%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$7.989M -$4.716M -$5.869M
YoY Change 69.4% -53.79% -42.81%
Depreciation, Depletion And Amortization $136.0K $90.00K $190.0K
YoY Change 51.11% 35.71%
Cash From Operating Activities -$5.500M -$5.360M -$16.93M
YoY Change 2.61% 58.82%
INVESTING ACTIVITIES
Capital Expenditures -$180.0K -$50.00K -$150.0K
YoY Change 260.0% -55.88%
Acquisitions
YoY Change
Other Investing Activities $9.241M $0.00 $20.10M
YoY Change
Cash From Investing Activities $9.061M -$50.00K $19.95M
YoY Change -18222.0% -5967.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 27.00K 82.83M -1.340M
YoY Change -99.97% -13500.0%
NET CHANGE
Cash From Operating Activities -5.500M -5.360M -16.93M
Cash From Investing Activities 9.061M -50.00K 19.95M
Cash From Financing Activities 27.00K 82.83M -1.340M
Net Change In Cash 3.588M 77.42M 1.680M
YoY Change -95.37% -115.29%
FREE CASH FLOW
Cash From Operating Activities -$5.500M -$5.360M -$16.93M
Capital Expenditures -$180.0K -$50.00K -$150.0K
Free Cash Flow -$5.320M -$5.310M -$16.78M
YoY Change 0.19% 62.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4490000
CY2021Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
12000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4757000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14635000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15474000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2064000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12611000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4021000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3996000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7989000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7989000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21287498
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5183000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.28
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.52
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25568000
us-gaap Net Income Loss
NetIncomeLoss
-27146000
us-gaap Net Income Loss
NetIncomeLoss
-18379000
us-gaap Operating Expenses
OperatingExpenses
27246000
us-gaap Operating Expenses
OperatingExpenses
20657000
us-gaap Operating Income Loss
OperatingIncomeLoss
-27246000
us-gaap Operating Income Loss
OperatingIncomeLoss
-20657000
us-gaap Investment Income Interest
InvestmentIncomeInterest
100000
us-gaap Investment Income Interest
InvestmentIncomeInterest
120000
CY2020Q3 gray Change In Fair Value Of Preferred Stock Tranche Obligation
ChangeInFairValueOfPreferredStockTrancheObligation
2102000
gray Change In Fair Value Of Preferred Stock Tranche Obligation
ChangeInFairValueOfPreferredStockTrancheObligation
2158000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4716000
us-gaap Net Income Loss
NetIncomeLoss
-27146000
us-gaap Net Income Loss
NetIncomeLoss
-18379000
CY2020Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
2396000
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
7189000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7112000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27146000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-13.74
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2818349
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21153185
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1861229
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18382000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
94786000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-11449000
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
4000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
84562000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
495000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1312000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-7708000
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
6000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
78667000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1431000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7989000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
72136000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-102954000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
226000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7794000
CY2020Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-110514000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
214000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5869000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-116157000
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
79529000
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
131363000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
561000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4716000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
90634000
us-gaap Profit Loss
ProfitLoss
-27146000
us-gaap Profit Loss
ProfitLoss
-18379000
us-gaap Share Based Compensation
ShareBasedCompensation
3872000
us-gaap Share Based Compensation
ShareBasedCompensation
1001000
us-gaap Depreciation
Depreciation
383000
us-gaap Depreciation
Depreciation
284000
gray Change In Fair Value Of Preferred Stock Tranche Obligation
ChangeInFairValueOfPreferredStockTrancheObligation
2158000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-74000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
17000
gray Increase Decrease In Prepaid Expenses And Other Current And Noncurrent Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets
-2844000
gray Increase Decrease In Prepaid Expenses And Other Current And Noncurrent Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets
-227000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-513000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1204000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1092000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1310000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-968000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-747000
gray Increase Decrease In Deferred Liabilities Non Current
IncreaseDecreaseInDeferredLiabilitiesNonCurrent
1000
gray Increase Decrease In Deferred Liabilities Non Current
IncreaseDecreaseInDeferredLiabilitiesNonCurrent
10000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22545000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22293000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
484000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
197000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
72610000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
73059000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
20100000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19903000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
83700000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
614000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
77000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2289000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
614000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
81488000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21966000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
79098000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33418000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15870000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11452000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
94968000
gray Deferred Offering Costs Included In Accounts Payable And Other Current Liabilities
DeferredOfferingCostsIncludedInAccountsPayableAndOtherCurrentLiabilities
1837000
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
131363000
gray Property And Equipment Purchases Included In Accounts Payable And Other Current Liabilities
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndOtherCurrentLiabilities
115000
gray Property And Equipment Purchases Included In Accounts Payable And Other Current Liabilities
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndOtherCurrentLiabilities
60000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-160500000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates   </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.68%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates, including those related to accrued research and development expenses, other long-lived assets, stock-based compensation and the valuation of deferred tax assets. </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.68%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company bases its estimates using historical experience, Company forecasts and future plans, current economic conditions, and information from third-party professionals that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and recorded amounts of expenses that are not readily apparent from other sources, and adjusts those estimates and assumptions when facts and circumstances dictate.</p>
CY2021Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
8133000
CY2021Q3 gray Short Term Investment Fair Value Disclosure
ShortTermInvestmentFairValueDisclosure
61102000
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
69235000
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
31676000
CY2020Q4 gray Short Term Investment Fair Value Disclosure
ShortTermInvestmentFairValueDisclosure
61615000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
93291000
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2020 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2021Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
374000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2160000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
425000
CY2021Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
5000
CY2020Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
27000
CY2021Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
346000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1465000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2302000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
344000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3128000
CY2020Q4 gray Contractual Termination Obligation
ContractualTerminationObligation
3700000
gray Unpaid Cancellation And Other Related Costs
UnpaidCancellationAndOtherRelatedCosts
0
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
175000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
192000
us-gaap Operating Lease Expense
OperatingLeaseExpense
553000
us-gaap Operating Lease Expense
OperatingLeaseExpense
544000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
146000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
527000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
205000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
878000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1001000
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
16900000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M6D
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
2400000
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
7200000

Files In Submission

Name View Source Status
0001564590-21-056418-index-headers.html Edgar Link pending
0001564590-21-056418-index.html Edgar Link pending
0001564590-21-056418.txt Edgar Link pending
0001564590-21-056418-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gray-10q_20210930.htm Edgar Link pending
gray-10q_20210930_htm.xml Edgar Link completed
gray-20210930.xsd Edgar Link pending
gray-20210930_cal.xml Edgar Link unprocessable
gray-20210930_def.xml Edgar Link unprocessable
gray-20210930_lab.xml Edgar Link unprocessable
gray-20210930_pre.xml Edgar Link unprocessable
gray-ex311_7.htm Edgar Link pending
gray-ex312_8.htm Edgar Link pending
gray-ex321_6.htm Edgar Link pending
gray-ex322_9.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending